In Gujarat, the escalating flu season has brought a surge in demand for Oseltamivir, the primary antiviral medication for managing severe flu symptoms and respiratory infections. With cases of H1N1 (swine flu) and other serious flu strains on the rise, Oseltamivir sales have jumped by a notable 33% over the past two years. Medical practitioners report a marked increase in severe cases requiring antiviral prescriptions, driven in part by persistent warm weather and significant day-to-night temperature fluctuations that have impacted respiratory health across the state.
According to Pharmarack data, the sales value of Oseltamivir in Gujarat rose from Rs 6 crore in September 2022 to Rs 8 crore in September 2024. Year-on-year sales growth reached 14.5% as Oseltamivir sales climbed from Rs 7 crore in 2023. This trend is indicative of a greater reliance on antivirals for managing flu symptoms amid an unusually severe season. Many healthcare providers link these rising numbers to temperature shifts, which have amplified the incidence and severity of upper respiratory infections across communities.
The high flu burden is further compounded by the reluctance among some patients to undergo costly diagnostic testing. Fever panel tests, ranging between Rs 4,000 and Rs 6,000, are often bypassed in favour of a more affordable course of Oseltamivir, priced around Rs 500. Medical practitioners are increasingly recommending early administration of the antiviral, particularly for those with underlying health conditions like diabetes or cardiovascular diseases, to mitigate complications such as pneumonia. This economic barrier highlights a broader public health challenge: balancing effective treatment with accessible care options during seasonal outbreaks.
Doctors have observed that reduced mask usage post-COVID has also contributed to the uptick in severe flu cases, especially in urban settings where dense populations exacerbate viral spread. A physician from Maninagar emphasised that while masks had previously acted as a barrier, their reduced usage has led to heightened exposure to infections. “We are observing an increase in cases, particularly among those with pre-existing conditions who face severe symptoms and high-grade fevers. The sustained respiratory issues underscore the need for preventive measures amid changing weather patterns,” he explained.
This flu wave also draws attention to sustainability concerns, as the increased reliance on medication highlights the need for improved public health strategies. Ensuring accessible healthcare options and affordable diagnostics is crucial for managing seasonal infections in a sustainable way. With flu cases rising each year, comprehensive approaches involving preventive health measures, public awareness, and climate resilience are essential in promoting urban health stability and reducing reliance on medical interventions like Oseltamivir.
